JENBURKT PHARMACEUTICALS
Back to Income Statement
|
JENBURKT PHARMACEUTICALS Last 5 Year Revenue History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹152 Cr | ₹142 Cr | ₹137 Cr | ₹124 Cr | ₹109 Cr |
What is the latest Revenue of JENBURKT PHARMACEUTICALS ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹152 Cr |
| Mar2024 | ₹142 Cr |
| Mar2023 | ₹137 Cr |
| Mar2022 | ₹124 Cr |
| Mar2021 | ₹109 Cr |
How is Revenue of JENBURKT PHARMACEUTICALS Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹152 Cr | 6.85 | |
| Mar2024 | ₹142 Cr | 3.82 | |
| Mar2023 | ₹137 Cr | 10.30 | |
| Mar2022 | ₹124 Cr | 13.44 | |
| Mar2021 | ₹109 Cr | - | |
Compare Revenue of peers of JENBURKT PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| JENBURKT PHARMACEUTICALS | ₹486.0 Cr | 3.5% | -2.7% | -8.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹408,559.0 Cr | 7.1% | -1.5% | -6.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹164,827.0 Cr | 2.8% | -2.8% | 6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹136,942.0 Cr | 3.1% | 4.2% | 18.8% | Stock Analytics | |
| CIPLA | ₹106,825.0 Cr | 0.2% | -12.5% | -7.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,077.0 Cr | 2.2% | -1.6% | 0% | Stock Analytics | |
JENBURKT PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| JENBURKT PHARMACEUTICALS | 3.5% |
-2.7% |
-8.5% |
| SENSEX | 1.7% |
-1.7% |
10.3% |
You may also like the below Video Courses